Suppr超能文献

X 连锁遗传性运动感觉神经病。

X-linked Charcot-Marie-Tooth disease.

机构信息

Department of Neurology, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

J Peripher Nerv Syst. 2012 Dec;17 Suppl 3(0 3):9-13. doi: 10.1111/j.1529-8027.2012.00424.x.

Abstract

The X-linked form of Charcot-Marie-Tooth disease (CMT1X) is the second most common form of hereditary motor and sensory neuropathy. The clinical phenotype is characterized by progressive muscle atrophy and weakness, areflexia, and variable sensory abnormalities; central nervous system manifestations occur, too. Affected males have moderate to severe symptoms, whereas heterozygous females are usually less affected. Neurophysiology shows intermediate slowing of conduction and distal axonal loss. Nerve biopsies show more prominent axonal degeneration than de/remyelination. More than 400 different mutations in GJB1, the gene that encodes the gap junction (GJ) protein connexin32 (Cx32), cause CMT1X. Many Cx32 mutants fail to form functional GJs, or form GJs with abnormal biophysical properties. Schwann cells and oligodendrocytes express Cx32, and the GJs formed by Cx32 play an important role in the homeostasis of myelinated axons. Animal models of CMT1X demonstrate that loss of Cx32 in myelinating Schwann cells causes a demyelinating neuropathy. An effective therapy remains to be developed.

摘要

X 连锁型腓骨肌萎缩症(CMT1X)是遗传性运动感觉神经病中第二常见的形式。其临床表型的特点是进行性肌肉萎缩和无力、反射消失以及各种感觉异常;中枢神经系统也会受到影响。患病男性的症状较为严重,而杂合子女性的症状通常较轻。神经生理学显示传导速度中度至重度减慢和远端轴突丢失。神经活检显示更明显的轴突变性而脱髓鞘/髓鞘再生较少。超过 400 种不同的 GJB1 基因突变导致 X 连锁型腓骨肌萎缩症,该基因编码间隙连接(GJ)蛋白连接蛋白 32(Cx32)。许多 Cx32 突变体无法形成功能性 GJ,或形成具有异常物理特性的 GJ。许旺细胞和少突胶质细胞表达 Cx32,由 Cx32 形成的 GJ 在髓鞘轴突的动态平衡中发挥重要作用。CMT1X 的动物模型表明,髓鞘形成许旺细胞中 Cx32 的缺失会导致脱髓鞘神经病。仍需要开发有效的治疗方法。

相似文献

1
X-linked Charcot-Marie-Tooth disease.
J Peripher Nerv Syst. 2012 Dec;17 Suppl 3(0 3):9-13. doi: 10.1111/j.1529-8027.2012.00424.x.
2
How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease?
Brain Res. 2012 Dec 3;1487:198-205. doi: 10.1016/j.brainres.2012.03.068. Epub 2012 Jul 6.
3
Molecular genetics of X-linked Charcot-Marie-Tooth disease.
Neuromolecular Med. 2006;8(1-2):107-22. doi: 10.1385/nmm:8:1-2:107.
4
Connexins, gap junctions and peripheral neuropathy.
Neurosci Lett. 2015 Jun 2;596:27-32. doi: 10.1016/j.neulet.2014.10.033. Epub 2014 Oct 24.
5
Genetic epidemiology of Charcot-Marie-Tooth disease.
Acta Neurol Scand Suppl. 2012(193):iv-22. doi: 10.1111/ane.12013.
6
Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy.
J Neuropathol Exp Neurol. 2010 Sep;69(9):945-58. doi: 10.1097/NEN.0b013e3181efa658.
7
GJB1-associated X-linked Charcot-Marie-Tooth disease, a disorder affecting the central and peripheral nervous systems.
Cell Tissue Res. 2015 Jun;360(3):659-73. doi: 10.1007/s00441-014-2014-6. Epub 2014 Nov 5.
8
Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X.
Neurology. 2006 Feb 14;66(3):396-402. doi: 10.1212/01.wnl.0000196479.93722.59.
9
Intrathecal gene therapy in mouse models expressing CMT1X mutations.
Hum Mol Genet. 2018 Apr 15;27(8):1460-1473. doi: 10.1093/hmg/ddy056.

引用本文的文献

1
Cemdomespib Therapy Slows the Progression of Neuromuscular Weakness and Demyelination in the R75W-Connexin 32 Animal Model of Charcot-Marie-Tooth 1X Disease.
ACS Pharmacol Transl Sci. 2024 Dec 13;8(1):124-135. doi: 10.1021/acsptsci.4c00464. eCollection 2025 Jan 10.
3
From BBB to PPP: Bioenergetic requirements and challenges for oligodendrocytes in health and disease.
J Neurochem. 2025 Jan;169(1):e16219. doi: 10.1111/jnc.16219. Epub 2024 Sep 10.
4
The Current State of Charcot-Marie-Tooth Disease Treatment.
Genes (Basel). 2023 Jul 1;14(7):1391. doi: 10.3390/genes14071391.
6
Pharmacologic Targeting of the C-Terminus of Heat Shock Protein 90 Improves Neuromuscular Function in Animal Models of Charcot Marie Tooth X1 Disease.
ACS Pharmacol Transl Sci. 2023 Jan 20;6(2):306-319. doi: 10.1021/acsptsci.2c00223. eCollection 2023 Feb 10.
7
Intramembrane client recognition potentiates the chaperone functions of calnexin.
EMBO J. 2022 Dec 15;41(24):e110959. doi: 10.15252/embj.2022110959. Epub 2022 Oct 31.
8
Phenotypic characterization of c.379A > G GJB1 mutation in a Charcot-Marie-Tooth female patient.
Acta Neurol Belg. 2023 Oct;123(5):2031-2033. doi: 10.1007/s13760-022-02093-x. Epub 2022 Sep 29.
9
The Complex and Critical Role of Glycine 12 (G12) in Beta-Connexins of Human Skin.
Int J Mol Sci. 2021 Mar 5;22(5):2615. doi: 10.3390/ijms22052615.
10
Schwann cell interactions during the development of the peripheral nervous system.
Dev Neurobiol. 2021 Jul;81(5):464-489. doi: 10.1002/dneu.22744. Epub 2020 May 5.

本文引用的文献

1
Phenotype expression in women with CMT1X.
J Peripher Nerv Syst. 2011 Jun;16(2):102-7. doi: 10.1111/j.1529-8027.2011.00332.x.
2
Charcot-Marie-Tooth disease subtypes and genetic testing strategies.
Ann Neurol. 2011 Jan;69(1):22-33. doi: 10.1002/ana.22166.
3
Structural and functional studies of gap junction channels.
Curr Opin Struct Biol. 2010 Aug;20(4):423-30. doi: 10.1016/j.sbi.2010.05.003. Epub 2010 Jun 9.
5
Human oligodendrocytes express Cx31.3: function and interactions with Cx32 mutants.
Neurobiol Dis. 2008 May;30(2):221-33. doi: 10.1016/j.nbd.2008.01.009. Epub 2008 Feb 15.
7
CMT1X phenotypes represent loss of GJB1 gene function.
Neurology. 2007 Mar 13;68(11):849-55. doi: 10.1212/01.wnl.0000256709.08271.4d.
8
The effects of a dominant connexin32 mutant in myelinating Schwann cells.
Mol Cell Neurosci. 2006 Jul;32(3):283-98. doi: 10.1016/j.mcn.2006.05.001. Epub 2006 Jun 21.
9
SIMPLE mutation analysis in dominant demyelinating Charcot-Marie-Tooth disease: three novel mutations.
J Peripher Nerv Syst. 2006 Jun;11(2):148-55. doi: 10.1111/j.1085-9489.2006.00080.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验